"Secondly, the findings underscore the importance of regulatory bodies considering 'off-target and cross class' effects when approving new drugs. For antibiotics, this means understanding whether ...
We also prioritized compounds that work differently from existing antibiotics to minimize cross-resistance. Finally, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback